NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of BellRing Brands, Inc. ("BellRing Brands, Inc.") (NYSE:BRBR) concerning possible violations of federal securities laws. On May 6, 2025, BellRing Brands during its second quarter of 2025 earnings call revealed that certain customers […]

(NASDAQ:AVDX), CHARLOTTE, N.C., Aug. 06, 2025 (GLOBE NEWSWIRE) — AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leading provider of accounts payable (AP) automation software and payment solutions for middle market businesses and their suppliers, today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights: Total revenue was $110.6 million,

AvidXchange Announces Second-Quarter 2025 Financial Results GlobeNewswire August 07, 2025 CHARLOTTE, N.C., Aug. 06, 2025 (GLOBE NEWSWIRE) — AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leading provider of accounts payable (AP) automation software and payment solutions for middle market businesses and their suppliers, today announced financial results for the second quarter ended June 30, 2025. Second

(NASDAQ:ASTS), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In SpaceMobile (ASTS) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in SpaceMobile between November 14, 2023 to April 1, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire

SPACEMOBILE (ASTS) ALERT: Bragar Eagel & Squire, P.C. is Investigating AST SpaceMobile, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm GlobeNewswire August 06, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In SpaceMobile (ASTS) To Contact Him Directly To Discuss Their Options If

Strategic partnership leverages AI and robotics for novel therapeutics across oncology, immunology, inflammation, neurology, and metabolic diseases. XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced a transformative strategic collaboration with DoveTree Medicines, a biotechnology pioneer founded by renowned drug developer Dr. Gregory Verdine.

Stibnite Gold Project Listed as a White House Transparency Project Perpetua Anticipates 550+ Direct Jobs in Idaho during operations Perpetua Announces Stibnite Launch Scholarship with College of Western Idaho Today, U.S. Secretary of Labor Lori Chavez-DeRemer and Idaho Governor Brad Little met with Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) (“Perpetua Resources” or “Perpetua” or

(NASDAQ:REPL), SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent investors who purchased or otherwise acquired Replimune (NASDAQ: REPL) securities between November 22, 2024 and July 21, 2025. The lawsuit comes after

NEW YORK CITY, NY / ACCESS Newswire / August 6, 2025 / WHY: New York, N.Y., August 6, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ:CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the "Class Period"), of the important September

Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug – Hagens Berman REPL Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire August 06, 2025 SAN FRANCISCO, Aug. 06, 2025 (GLOBE NEWSWIRE) — A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D.